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Background: Although some data suggest that the individual genetic predisposition
for developing major or minor degrees of postoperative systemic inflammatory
reaction may influence postoperative morbidity, this hypothesis has not been clin-
ically tested to date.
Methods and Results: The 174 G/C polymorphism of the promoter of the
interleukin 6 gene was determined preoperatively in 111 consecutive patients
submitted to primary isolated coronary artery bypass. The results of the genetic
analysis were then correlated with the postoperative interleukin 6 levels and the
development of postoperative renal and pulmonary complications. G homozygotes
had significantly higher interleukin 6 levels postoperatively (P  .0001 for the
difference between areas under the curve). These patients also had worse postop-
erative pulmonary and renal function. The mean perioperative difference in serum
creatinine, potassium, and nitrogen was 0.82  0.34, 0.99  0.44, and 10.1  7.8
mg/dL versus 0.18  0.14, 0.15  0.48, and 2.6  4.1 mg/dL for GG versus
non-GG carriers (P  .0001), respectively. The mean respiratory index at 6 and 12
hours was 2.9  0.8 and 2.8  0.3 versus 2.1  0.5 and 1.3  0.1, respectively (P
 .0001). The mean duration of mechanical ventilation was 22.5  2.1 versus 12.7
 6.7 hours (P  .01). A correlation was found between postoperative interleukin
6 levels and renal and pulmonary complications.
Conclusion: The interleukin 6 174 G/C polymorphism modulates postoperative
interleukin 6 levels and is associated with the degree of postoperative renal and
pulmonary dysfunction and in-hospital stay after coronary surgery.
Although there is general agreement that the inflammatory reactioninduced by extracorporeal circulation plays a major role in deter-mining morbidity after cardiac surgery,1,2 the modulators of thesystemic damage are not yet fully understood, and, most impor-tant, the development of postoperative complications is largelyunpredictable at the moment (with the exception of cases with
clear-cut preoperative organ dysfunction).3
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The kidneys and the lungs are probably the main target
of the postoperative systemic inflammatory reaction. A sub-
clinical degree of renal and pulmonary impairment is
thought to occur after almost any cardiac operation, and
pulmonary and renal complications account for a great part
of postoperative morbidity after cardiac surgical proce-
dures.4-6
The individual genetic background could theoretically
modulate the magnitude of the postoperative systemic in-
flammatory reaction and, thus, contribute to a greater or
lesser propensity for both renal and pulmonary complica-
tions.
This hypothesis is supported by recent preliminary data
from our group showing that postoperative levels of inter-
leukin 6 (IL-6, one of the principal mediators of the inflam-
matory response to cardiopulmonary bypass [CPB]) are
genetically modulated by the single-base promoter mutation
IL-6 174 G/C and that the G homozygosis for this poly-
morphism predicts postoperative in-hospital stay after cor-
onary surgery. However, in this preliminary analysis, post-
operative outcome was measured by simple clinical indexes
and no correlation between genetic status and morbidity
could be found.7
The present study investigated, in the same cohort of
cases, whether the described longer postoperative course of
G homozygotes is related to a greater incidence of pulmo-
nary and renal dysfunction (evaluated using sensible in-
dexes) and if postoperative IL-6 levels could be correlated
with the development of pulmonary and renal complica-
tions.
Patients and Methods
Patient Population
From January 1998, all patients scheduled to undergo elective
isolated coronary revascularization surgery at our institution were
screened for inclusion in a study on the hemostatic and inflamma-
tory reaction to CPB (Fibrinolisi ed Infiammazione nella Fase
Acuta [FIFA] study). Preliminary results of this study have already
been published.7,8
To maximize homogeneity and to reduce patient-related con-
founding factors, rigorous exclusion criteria were adopted to ob-
tain a highly selected population of patients with triple vessel
surgical coronary artery disease without concomitant systemic
pathologies. Exclusion criteria were as follows: (1) associated
cardiac or noncardiac surgical procedures; (2) age greater than 80
years; (3) single vessel disease; (4) emergency or urgent revascu-
larization; (5) left ventricular ejection fraction less than 0.30; (6)
significant carotid artery disease (50% stenosis); (7) previous
cerebrovascular accident; (8) long-term dialysis; (9) respiratory or
renal insufficiency (defined, respectively, as a preoperative creat-
inine level of  2.0 mg/dL and a preoperative PO2 of  60 mm Hg
or PCO2  50 mm Hg in current air and/or a preoperative forced
expiratory volume in 1 second [FEV1]  1.25 L or  75% of the
normal value); (10) hemorrhagic conditions; (11) active infection;
and, (12) chronic anti-inflammatory therapy (defined as the daily
use of either corticosteroids or nonsteroidal anti-inflammatory
drugs for more than 1 month). Data collection ended in May 1999
and, for this period, a total of 113 cases were included. The study
received ethical committee approval and all included patients gave
their consent to participate. Genetic analysis could not be per-
formed in 2 cases so that the present report refers to 111 patients.
Surgical Technique
The anesthetic procedures were standardized for all patients: they
received their medication until the day of the operation and were
premedicated with diazepam (0.15 mg/kg), morphine (0.15 mg/
kg), and scopolamine (0.01 mg/kg). After induction with sodium
thiopental (2-3 mg/kg), balanced anesthesia was performed with
isoflurane, fentanyl, and boluses of midazolam and propofol as
needed to maintain hypnosis. Muscle relaxation was ensured by
the administration of pancuronium bromide (0.1 mg/kg). Antico-
agulation was obtained with heparin 300 IU/kg, and an activated
clotting time greater than 480 seconds was maintained. Heparin
neutralization was achieved with protamine hydrochloride (1.3
mg/mg heparin). In no patients were agents with renal effects used
preoperatively and in no cases were antifibrinolytic drugs used in
the perioperative period. All surgical procedures were performed
in standard fashion by the same surgical team through median
sternotomy and with CPB.
As the FIFA study had as secondary end point the assessment
of the effect of CPB temperature on postoperative inflammatory
and fibrinolytic activation, patients were randomized to a CPB
nasopharyngeal temperature of 37°C (55 patients) or 26°C (58
patients). The results of the study on CPB temperature have been
described in a separate report8; in summary, no differences in
inflammatory and fibrinolytic activation were found between pa-
tients operated on with normothermic versus hypothermic CPB.
Myocardial protection was always accomplished by antegrade
intermittent blood cardioplegia isothermic to CPB temperature.
IL-6 Promoter Polymorphism Analysis
For genetic analyses, blood was drawn immediately before sur-
gery. Citrated samples were centrifuged without delay at 3000g for
20 minutes; cellular pellets were stored at 20°C. DNA was
extracted by standard techniques. 174 G/C IL-6 promoter geno-
typing was performed according to a method described previous-
ly.9 This polymorphism was chosen for its demonstrated role in the
control of plasma IL-6 levels.9
IL-6 Dosage
The plasma concentrations of IL-6 were determined in each patient
(1) preoperatively; (2) 24, 48, and 72 hours after the operation;
and, (3) at hospital discharge. The assay was performed in a core
laboratory blinded to the patients’ status using the IL-6 Human
Biotrak Elisa System (Amersham Pharmacia Biotech Inc, Piscat-
away, NJ).
Evaluation of Postoperative Outcome
To avoid investigator-related biases, all the physicians involved in
patients’ care were blinded to the results of the genetic and
biochemical analyses, which were performed in a core laboratory
by operators blinded to patients’ clinical course. The in-hospital
clinical courses of all patients, including major and minor postop-
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erative complications, mean duration of mechanical ventilation,
and stay in the intensive care unit, were prospectively recorded.
Daily blood samples were obtained postoperatively until hospital
discharge, per institutional routine, and used for the clinical man-
agement after surgery.
To evaluate even subclinical variations of the pulmonary
function, the respiratory index (defined as P(A-a)O2/PaO2, where
P(A-a)O2 is the alveolar-arterial difference for PO2 and PaO2 the
arterial PO2) was calculated for each patient at 6 and 12 hours.
For a sensible evaluation of the renal function the following
parameters were adopted:
1. Perioperative difference in serum creatinine, nitrogen, and
potassium (-Creat, -BUN, and -K, respectively): these
indexes were evaluated by calculating the difference be-
tween the highest in-hospital postoperative value and the
preoperative value (defined as the one obtained closest to
surgery), according to a method previously validated by
others.10
2. Need for dopamine stimulus at renal dosage (3.0 g · kg1
· min1) and/or need for extra diuretic stimulus (defined as
a furosemide dosage  1 mg/kg in 24 hours or furosemide
plus any other diuretic): both these therapeutic measures
were decided by the cardiac anesthesiologist on duty on a
clinical basis and to maintain a diuresis  0.5/mL · kg1 ·
min1.
Statistical Analysis
The 2 or Fisher exact tests were used to compare discrete param-
eters. To remove skewness, logarithms were applied to data when
appropriate, although untransformed data are shown. Continuous
variables (presented as means  SD) were compared by paramet-
ric (or nonparametric, when data remained skewed) analysis of
variance. Relationships among continuous variables were mea-
sured by the Spearman correlation test and multivariate regression
analysis. Association between genotype and categorical variables
was assessed with the use of multivariate logistic regression anal-
ysis in a model that included the major clinical variables and the
most accepted risk factors for renal and pulmonary complications.
These are as follows: (1) age; (2) sex; (3) preoperative creatinine
value; (4) CPB temperature; (5) hypertension; (6) hypercholester-
olemia; (7) previous myocardial infarction, angina, or cardiac
failure; (8) major and minor postoperative complications; (9) time
spent in the intensive care unit; and, (10) time spent in the hospital.
Differences in continuous variables according to genotypes
were assessed with a multivariate analysis of variance
(MANOVA) approach, using general linear models (GLM proce-
dure for SAS), including as covariates the same variables used in
logistic regression. MANOVA was used to test the hypothesis of
no overall effect of polymorphism on the set of indexes of pul-
monary or renal complications. The area under the curve of the
postoperative IL-6 values was calculated by the Simpson method
with the trapezium division areas: [(Y preoperative  Y 24 hours
postoperative)/2 * T1] [(Y 24 hours postoperative Y 48 hours
postoperative)/2 * T2]  [( Y 48 hours postoperative  Y 72
hours postoperative) /2 * T3]  [(Y 72 hours postoperative  Y
predischarge)/2 * T4], where T1-T4 are the different time intervals
in hours (T1, from the preoperative time to 24 hours postopera-
tively; T2, from 24 to 48 hours postoperatively; T3, from 48 to 72
hours postoperatively; and, T4, from 72 hours postoperatively to
before discharge) and Y is the IL-6 value.
Analyses were carried out with the SAS statistical package
(SAS/STAT User Guide, version 8.1, SAS Institute, Inc, Cary,
NC).
Results
Overall Clinical Results
Detailed in-hospital clinical results of this cohort of patients
have already been described in detail elsewhere8 and are
summarized in Table 1. Two in-hospital deaths occurred
due to massive pulmonary embolism (on the third postop-
erative day) and myocardial infarction (8 days after the
operation). Postoperatively, 4 patients had nonfatal myocar-
dial infarction, 1 patient had a septic syndrome, and 2
patients had to be reoperated on for clinical or instrumental
evidence of graft malfunction. Eight patients needed a sur-
gical revision of the hemostasis and 28 needed a blood
transfusion. Mean stay in the intensive care unit and in the
hospital after surgery were 2.2  3.7 and 6.0  3.0 days,
respectively.
IL-6 Promoter Polymorphism Analysis
Genetic analysis revealed GG genotype in 62 patients, GC
in 39, and CC in 10, a distribution that did not differ
significantly from that predicted by the Hardy-Weinberg
equilibrium law (P  .29). Allele frequencies were 0.73
(95% CI: 0.68-0.79) for G and 0.27 (95% CI: 0.21-0.32) for
C. G homozygotes did not differ significantly from C-allele
carriers for baseline clinical and surgical characteristics (see
Table 2, P  .05 for all comparisons).
Evaluation of Postoperative IL-6 Levels
There was a significant effect of genotype on IL-6 levels; G
homozygotes had significantly higher IL-6 levels postoper-
TABLE 1. Postoperative mortality and morbidity in the
whole series of patients
Characteristics
Frequency or
mean  SD
Death 2
Stroke 0
Myocardial infarction 5
Sepsis 1
Shock 1
Reoperation 2
Postoperative bleeding (mL/24 h) 753  218
Revision for bleeding 8
Atrial fibrillation 24
Need for blood transfusion 28
Mean intensive care unit stay (d) 2.2  2.7
Mean postoperative stay (d) 6.0  3.0
As already reported,7 no differences in clinical outcome were found
between GG and C-allele carriers. The rate of major in-hospital complica-
tions and death was 8% for GG versus 2% for C carriers, P  .1.
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atively than C-allele carriers (P  .0001 for difference
between areas under the curve).
Evaluation of Postoperative Renal and Pulmonary
Function in the Whole Population and in Relation to
IL-6 Promoter Polymorphism
In the overall population, the mean perioperative differ-
ences in serum creatinine, nitrogen, and potassium were
0.53  0.41, 6.86  7.44, and 0.60  0.63, respectively.
Two patients had overt renal insufficiency necessitating
temporary hemodyalisis, 44 patients required extra diuretic
stimulus, and 21 patients required dopamine at renal dosage
in the postoperative period. Two patients had postoperative
respiratory insufficiency, and the mean duration of mechan-
ical ventilation was 18.02  16.56 hours; the mean respi-
ratory index at 6 hours was 2.56 0.75 and at 12 hours was
2.12  0.77.
Analysis of postoperative renal function in relation to the
IL-6 promoter polymorphism demonstrated a strong asso-
ciation between G homozygosity and increases in all the
investigated renal function indexes (overall effect P 
.0001, see Tables 3 and 4). Similarly, analysis of the indexes
of postoperative pulmonary function in relation to the IL-6
promoter polymorphism showed that G homozygotes had
worse respiratory indexes at both 6 and 12 hours and longer
ventilation time (overall effect P  .0001, Table 3).
As already reported, G homozygosity was associated
with longer stay both in the intensive care unit and in the
hospital (2.5  3.4 vs 1.4  0.9 days and 6.7  4.0 vs 5.3
 1.4 days, respectively; P  .02 for both).
Correlation Between Postoperative Renal and
Pulmonary Complications and IL-6 Levels
There was a strong correlation between postoperative IL-6
levels and most of the instrumental indexes of renal and
pulmonary complications considered. The area under the
curve of postoperative IL-6 correlated significantly with the
mean perioperative difference in serum creatinine (R 
0.65, P .031), with the respiratory index at 6 and 12 hours
(R 0.61, P .041 and R 0.58, P .041, respectively),
and with longer ventilation time (R  0.68, P  .029).
Similarly, patients who required postoperative use of dopa-
mine at renal dosage or needed extra diuretic stimulus had
significantly higher postoperative IL-6 values compared
with patients not having complications (P  .03 and .02,
respectively, for difference between areas under the curve).
No correlation was found between postoperative IL-6
levels and the mean perioperative difference in serum po-
tassium (R  0.03, P  .22) and for the -BUN (R  0.05,
P  .11).
Discussion
With almost 800,000 operations worldwide per year, coro-
nary artery bypass grafting is one of the most frequent
surgical procedures performed. The technical and techno-
logical improvements that have occurred in the past decade
have rendered this operation more safe. Despite that, ac-
cording to The Society of Thoracic Surgeons cardiac sur-
gery database, about 10% of patients have significant mor-
bidity after bypass grafting and more than 30% of them face
a postoperative complication.
The use of the extracorporeal circulation, and the conse-
quent whole body systemic inflammatory reaction, plays a
major role in determining postoperative morbidity after
bypass grafting. In fact, CPB acts as an enormous inflam-
matory stimulus and elicits a systemic inflammatory reac-
tion that is thought to be one of the main causes of postop-
erative organ dysfunction.1 The clinical consequences of
this CPB-induced systemic inflammatory reaction vary from
patient to patient, ranging from a subclinical increase in the
TABLE 2. Preoperative and intraoperative characteristics
of the patients according to IL-6 promoter polymorphism
Characteristics
All
(n  111)
GG
(n  62)
CG  CC
(n  49)
Age (y) 61 9 61 9 61 8
Male 103 (93%) 59 (95%) 44 (90%)
Current smoker 44 (42%) 24 (39%) 20 (45%)
Hypercholesterolemia 29 (27%) 16 (26%) 13 (28%)
Hypertension 70 (65%) 40 (65) 30 (65%)
Diabetes 23 (21%) 13 (21%) 10 (22%)
Preoperative serum
creatinine (mg/dL)
1.1 0.4 1.1 0.6 1.1 0.1
Previous myocardial
infarction
57 (53%) 31 (52%) 26 (54%)
Previous heart failure 5 (5%) 4 (7%) 1 (2%)
Diseased vessels
3 81 (73%) 47 (76%) 34 (69%)
2 20 (18%) 9 (15%) 10 (21%)
1  left main 10 (9%) 6 (9%) 5 (10%)
LVEF
0.50 82 (74%) 45 (73%) 37 (76%)
0.30–0.50 29 (26%) 17 (27%) 12 (24%)
Distal anastomoses:
2 21 (20%) 10 (16%) 11 (22%)
3 56 (50%) 32 (52%) 24 (49%)
4 29 (26%) 16 (26%) 13 (27%)
5 5 (4%) 4 (6%) 1 (2%)
Bypass conduits
LITA  GSV(s) 90 (81%) 49 (79%) 41 (84%)
GSV(s) 17 (15%) 10 (16%) 7 (14%)
LITA  RITA or
LRA
4 (4%) 3 (5%) 1 (2%)
CPB time (min) 74 20 76 21 71 18
Aortic clamp time
(min)
61 17 64 17 58 18
Normothermic CPB 55 (49%) 28 (45%) 27 (55%)
CPB, Cardiopulmonary bypass; GSV, great saphenous vein; LITA, left
internal thoracic artery; LRA, left radial artery; LVEF, left ventricular ejec-
tion fraction; RITA, right internal thoracic artery.
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humoral inflammatory indexes to multiple organ insuffi-
ciency and even death.1,2
The kidneys and the lungs are probably the main targets
of the postoperative systemic inflammatory reaction4-6; re-
nal and pulmonary dysfunction account for a large portion
of the global number of complications, worsening signifi-
cantly the short- and midterm prognosis of patients under-
going coronary bypass grafting.11-17
Traditionally, attempts to explain the heterogeneous clin-
ical expressions of the systemic inflammatory syndrome in
different patients and to quantify the individual surgical risk
have focused on the preoperative functional reserve of the
various organs and systems.3
The hypothesis of a genetic modulation of the inflam-
matory response to CPB and, thus, of the postoperative
outcome has received, to date, only limited attention. To the
best of our knowledge, only Chew and associates have
shown how postoperative renal dysfunction is associated
with the 4 polymorphism of the gene for the apolipoprotein
E, which plays a significant role in the mediation of the
inflammatory and tissue repair reactions.10
Recently, a preliminary study performed by our group
showed that another gene involved in the modulation of the
inflammatory reaction, the IL-6 gene promoter, modulates
the postoperative blood levels of the corresponding cytokine
and is associated with the duration of in-hospital and inten-
sive care unit stays.7 However, in the preliminary report, the
postoperative outcome was assessed by simple clinical cri-
teria and no correlation between the IL-6 174 G/C poly-
morphism and morbidity could be found.
The results of the present study conducted in the same
population using more sensible indexes for the evaluation of
postoperative outcome show that the IL-6 174 G/C geno-
type is strongly associated, not only with the magnitude of
the postoperative systemic inflammatory reaction but also
with the degree of postoperative renal and pulmonary dys-
function.
In fact, G homozygotes have significantly worse postop-
erative pulmonary and renal function than do C-allele car-
riers, and there is a strong correlation between the magni-
tude of the inflammatory reaction to surgery and
postoperative pulmonary and renal morbidity.
These data should be interpreted with consideration
given to the limitations of our study. Despite the fact that the
FIFA protocol is by far one of the largest prospective
studies on the postoperative inflammatory activation after
cardiac surgery, the sample size of our study does not allow
us to definitely rule out type II statistical errors, especially
with regard to the multivariable analysis. Moreover, the
clinical relevance of the markers of pulmonary and renal
dysfunction that we have chosen remains, at least in part,
undemonstrated. However, the strong statistical association
between G homozygosis, postoperative IL-6 levels, and
both pulmonary and renal dysfunction; the fact that the
method used for renal function evaluation has been vali-
dated in cardiac surgery patients by others;10 and the finding
TABLE 3. Postoperative indexes of renal and pulmonary function according to IL-6 promoter polymorphism (continuous
variables)
Index
CG  CC
(n  49) GG (n  62)
Univariate*
(P value)
Multivariate†
(P value)
Respiratory index at 6 hours 2.1 0.5 2.9 0.8 .0001 .0001
Respiratory index at 12 hours 1.3 0.1 2.8 0.3 .0001 .0001
Mechanical ventilation (h) 12.7 6.7 22.5 20.6 .0001 .01
Perioperative -creatinine 0.18 0.14 0.82 0.34 .0001 .0001
Perioperative -potassium 0.15 0.48 0.99 0.44 .0001 .0001
Perioperative -BUN 2.6 4.1 10.1 7.8 .0001 .0001
BUN, Blood urea nitrogen.
*Wilcoxon test.
†Multivariate analysis of variance.
TABLE 4. Postoperative indexes of renal function according to IL-6 promoter polymorphism (discrete variables)
Index
CG  CC
(n  49)
GG
(n  62)
Univariate
[OR (95% CI)]
Multivariate*
[OR (95% CI)]
Dialysis 0 1 (1.6%) 0.79 (0.05 to 12.91) †
Extra diuretic stimulus 5 (10.2%) 39 (62.9%) 14.9 (5.2 to 43.0) 16.5 (4.7 to 57.6)
Dopamine at renal dose 2 (4.1%) 19 (30.7%) 10.4 (2.3 to 47.2) 29.4 (3.5 to 248)
*Multivariate logistic regression analysis.
†Not performed due to the small number of events.
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that G homozygotes had a longer in-hospital stay after
surgery seem to limit the possibility that these consider-
ations can significantly affect the main findings of the study.
In conclusion, in a highly selected series of patients
undergoing primary isolated coronary artery bypass graft-
ing, we have found that the IL-6 174 G/C polymorphism
modulates the inflammatory response to surgery and, via
this, is associated with the degree of postoperative renal and
pulmonary dysfunction and with the length of in-hospital
stay. These findings confirm the major role of the postop-
erative systemic inflammatory reaction to CPB in determin-
ing pulmonary and renal complications after cardiac sur-
gery, and, for one of the first times, suggest the existence of
a genetic modulation of the postoperative outcome.
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